methylene blue has been researched along with Shock, Septic in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 20 (30.30) | 18.2507 |
2000's | 12 (18.18) | 29.6817 |
2010's | 15 (22.73) | 24.3611 |
2020's | 19 (28.79) | 2.80 |
Authors | Studies |
---|---|
Allam, R; Awad, H; Ibrahim, M; Ismail, R; Shehata, B; Youssef, O | 1 |
Chen, G; Lou, X; Xue, J | 1 |
Auxiliadora-Martins, M; Basile-Filho, A; Becari, C; Evora, PRB; Luis-Silva, F; Martins-Filho, OA; Menegueti, MG; Peres, LM; Petroski-Moraes, BC; Sato, L; Sepeda, CDR | 1 |
Caqui, P; Coronado Munoz, AJ; Domínguez-Rojas, JA; Sanchez, A | 1 |
Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
Albuquerque, AAS; de Castro, RSAP; Evora, PRB; Ferreira, CHF; Gonçalves-Ferri, WA; Oharomari, LK; Silva Lessa, DF | 1 |
Auxiliadora-Martins, M; Basile-Filho, A; Becari, C; Donadel, MD; Dos Reis Sepeda, C; Evora, PRB; Gallo, GB; Jordani, MC; Luis-Silva, F; Martins-Filho, OA; Menegueti, MG; Mestriner, F; Peres, LM; Petroski-Moraes, BC; Sato, L | 1 |
Aguilera-González, P; Aguirre-Avalos, G; Chávez-Peña, Q; Gómez-Partida, CA; Hernández, G; Ibarra-Estrada, M; Kattan, E; López-Pulgarín, JA; Mijangos-Méndez, JC; Ortiz-Macías, IX; Rico-Jauregui, U; Sandoval-Plascencia, L | 1 |
Czempik, PF; Krzych, ŁJ; Pluta, MP; Putowski, Z | 1 |
Dubey, D; Imran, A; Ray, P | 1 |
Aguirre-Avalos, G; Hernández, G; Ibarra-Estrada, M; Kattan, E | 1 |
Evans, H; Ho, VP; Kaafarani, H; Namias, N; Rattan, R; Zakrison, TL | 1 |
Sullivan, JB; Tchen, S | 1 |
Burns, SL; Saha, BK | 1 |
Brienza, N; Giglio, M; Paladini, A; Pasqualucci, A; Puntillo, F; Varrassi, G | 1 |
Scigliano, G; Scigliano, GA | 1 |
Bloom, A; Faisal, H; Gaber, AO | 1 |
Dinis-Oliveira, RJ; Durão, C; Pedrosa, F | 1 |
Annich, G; Ben-Ari, J; Bitterman, Y; Eytan, D; Hadash, A; Hubara, E | 1 |
Clark, RF; Darracq, MA; Lo, JC | 1 |
Fletcher, C; Le, N; Qawasmi, A; Roy, S; Udelhofen, K; Yadegarian, A; Zipkin, R | 1 |
Dumbarton, TC; Farah, N; Lehmann, C; Maxan, A; Minor, S; Nantais, J; Zhou, J | 1 |
Benner, K; Brown, B; Hayes, L; Prabhakaran, P; Rutledge, C | 1 |
Fischer, GW; Hosseinian, L; Levin, MA; Weiner, M | 1 |
Harding, SA; Hoffman, RS; Jang, DH | 1 |
Smolinske, S; Tataru, AP; Warrick, BJ | 1 |
Bopp, C; Burhenne, J; Flechtenmacher, C; Goeppert, B; Schirmacher, P; Warth, A | 1 |
Binnekade, JM; Daemen-Gubbels, CR; de Jong, M; Groeneveld, AB; Juffermans, NP; Vervloet, MG | 1 |
Mount, JC; Rowe, AS | 1 |
Foudraine, N; Heemskerk, S; Pickkers, P; Sleigh, J; van der Hoeven, JG; van Haren, FM | 1 |
Flynn, JD; Hatton, KW; McMahon Horner, D; Paciullo, CA | 1 |
Marschalek, C; Schramm, W | 1 |
Adrario, E; Donati, A; Pelaia, P; Preiser, JC | 1 |
Dumbarton, TC; Green, R; Minor, S; Yeung, CK | 1 |
Dumbarton, TC; Gorman, SK; Green, R; Loubani, O; Minor, S; White, F | 1 |
Coltrinari, R; Conti, G; Donati, A; Loggi, S; Münch, C; Pelaia, P; Pietropaoli, P; Preiser, JC | 1 |
Bjertnaes, LJ; Evgenov, OV | 1 |
Da-Silva, SS; Sajan, IS; Underwood, JP | 1 |
Mitaka, C | 1 |
Holtby, H; Taylor, K | 1 |
Kim, DS; Kim, WD; Kim, WS; Koh, Y; Lee, SD; Lim, CM; Park, BK; Shim, TS | 1 |
Donati, A; Preiser, JC | 1 |
Foudraine, NA; Heemskerk, S; Masereeuw, R; Peters, WH; Pickkers, P; Russel, FG; van der Hoeven, JG; van Haren, FM | 1 |
Carlier, E; De Backer, D; Kahn, RJ; Leeman, M; Lejeune, P; Preiser, JC; Roman, A; Vincent, JL | 1 |
Dellinger, RP; Hata, JS | 1 |
Manikis, P; Metz, G; Preiser, JC; Rogiers, P; Spapen, H; Vincent, JL; Zhang, H | 1 |
Marczin, N; Salzman, AL; Szabó, C; Tekeres, M | 1 |
Schneider, F | 1 |
Bronsveld, W; Daemen-Gubbels, CR; Groeneveld, AB; Groeneveld, PH; Thijs, LG; van Kamp, GJ | 1 |
Francis, S; Keaney, JF; Loscalzo, J; Loscalzo, JF; Puyana, JC; Stamler, JS | 1 |
Baker, CH; Sutton, ET | 1 |
Koch, HJ | 1 |
Bedos, JP; Gachot, B; Regnier, B; Veber, B; Wolff, M | 1 |
Schreiber, MD | 1 |
Carrion, V; Driscoll, W; Morin, FC; Steinhorn, RH; Thurin, S | 1 |
Brown, G; Frankl, D; Phang, T | 1 |
Andresen, M; Bugedo, G; Castillo, L; Dagnino, J; Dougnac, A; Espejo, J; Hernández, G; Letelier, LM | 1 |
Chen, SJ; Wu, CC; Yen, MH | 1 |
Alvarez, M; Andresen, M; Bugedo, G; Castillo, L; Dagnino, J; Díaz, O; Dougnac, A; Hernández, G | 1 |
Brar, R; Dee, L; Khadour, F; Kumar, A; Parrillo, JE; Schulz, R; Skorupa, G; Wang, P | 1 |
Azambuja, LA; Friedman, G; Oliveira, E; Oliveira, ES; Oliveira, RP; Sant'Anna, UL; Weingartner, R | 1 |
Chang, MS; Chen, CC; Chen, SA; Chiang, CE; Ding, PY; Lin, YC; Luk, HN | 1 |
Bjertnaes, LJ; Egorina, EM; Evgenov, NV; Evgenov, OV; Kirov, MY; Nedashkovsky, EV; Sovershaev, MA; Sveinbjørnsson, B | 1 |
Bjertnaes, LJ; Evgenov, OV; Sveinbjørnsson, B | 1 |
Hasselmann, M; Lutun, P; Schneider, F; Stoclet, JC; Tempé, JD | 1 |
Berbiguier, N; Culo, F; Galey, L; Marusić, M; Sabolović, D; Somogyi, L | 1 |
13 review(s) available for methylene blue and Shock, Septic
Article | Year |
---|---|
[Research progress of methylene blue in the treatment of sepsis and septic shock].
Topics: Cyclic GMP; Guanylate Cyclase; Humans; Methylene Blue; Nitric Oxide; Sepsis; Shock, Septic | 2021 |
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |
Successful Use of Methylene Blue in Catecholamine-Resistant Septic Shock: A Case Report and Short Literature Review.
Topics: Catecholamines; Humans; Methylene Blue; Nitric Oxide Synthase; Shock; Shock, Septic | 2023 |
Sepsis 2019: What Surgeons Need to Know.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Angiotensin II; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Carbapenem-Resistant Enterobacteriaceae; Drug Resistance, Multiple, Bacterial; Duration of Therapy; Enterobacteriaceae Infections; Enterococcus faecium; Enzyme Inhibitors; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Methicillin-Resistant Staphylococcus aureus; Methylene Blue; Organ Dysfunction Scores; Patient Care Bundles; Postoperative Complications; Practice Guidelines as Topic; Procalcitonin; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Shock, Septic; Staphylococcal Infections; Thiamine; Vancomycin-Resistant Enterococci; Vasoconstrictor Agents; Vitamin B Complex | 2020 |
Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock.
Topics: Blood Pressure; Catecholamines; Critical Care; Critical Illness; Humans; Hypotension; Intensive Care Units; Methylene Blue; Midodrine; Off-Label Use; Patient Safety; Shock, Septic; Vasoconstrictor Agents | 2020 |
The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
Topics: Humans; Methylene Blue; Nitric Oxide; Shock, Septic; Vasodilation; Vasoplegia | 2020 |
Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review.
Topics: Adult; Aged; Aged, 80 and over; Hemodynamics; Humans; Male; Methylene Blue; Microcirculation; Middle Aged; Sepsis; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2020 |
A review of methylene blue treatment for cardiovascular collapse.
Topics: Anaphylaxis; Enzyme Inhibitors; Humans; Methylene Blue; Shock; Shock, Septic | 2014 |
Methylene Blue: Magic Bullet for Vasoplegia?
Topics: Cardiac Surgical Procedures; Cardiovascular Agents; Hemodynamics; Humans; Liver Transplantation; Methylene Blue; Resuscitation; Shock, Septic; Treatment Outcome; Vasodilation; Vasoplegia | 2016 |
Methylene blue for the treatment of septic shock.
Topics: Clinical Trials as Topic; Guanylate Cyclase; Hemodynamics; Humans; Lung; Methylene Blue; Nitric Oxide; Randomized Controlled Trials as Topic; Retrospective Studies; Shock, Septic; Vasodilation | 2010 |
[Septic shock and NO].
Topics: Animals; Biomarkers; Guanidines; Guanylate Cyclase; Hemodynamics; Humans; Methylene Blue; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; omega-N-Methylarginine; Receptors, Cytoplasmic and Nuclear; Shock, Septic; Soluble Guanylyl Cyclase | 2004 |
Nitric oxide inhibition in the treatment of septic shock.
Topics: Animals; Humans; Methylene Blue; Nitric Oxide; Nitric Oxide Synthase; Shock, Septic | 1995 |
Methylene blue: NO panacea.
Topics: Administration, Inhalation; Animals; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Infant, Newborn; Methylene Blue; Nitric Oxide; Nitric Oxide Synthase; Shock, Septic | 1996 |
11 trial(s) available for methylene blue and Shock, Septic
Article | Year |
---|---|
Methylene blue versus vasopressin analog for refractory septic shock in the preterm neonate: A randomized controlled trial.
Topics: Hemodynamics; Humans; Infant; Infant, Newborn; Infant, Premature; Methylene Blue; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2022 |
Effect of methylene blue on hemodynamic and metabolic response in septic shock patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Hemodynamics; Humans; Hypotension; Methylene Blue; Middle Aged; Norepinephrine; Randomized Controlled Trials as Topic; Shock, Septic; Vasoconstrictor Agents; Young Adult | 2022 |
Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.
Topics: Humans; Methylene Blue; Sepsis; Shock, Septic; Vasoconstrictor Agents | 2023 |
A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Free Radical Scavengers; Hemodynamics; Humans; Male; Methylene Blue; Middle Aged; Nitric Oxide; Shock, Septic; Vascular Resistance | 2010 |
Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?
Topics: Adult; Aged; Blood Volume; Capillary Permeability; Cardiotonic Agents; Enzyme Inhibitors; Female; Guanylate Cyclase; Hemodynamics; Humans; Indocyanine Green; Infusions, Intravenous; Lactic Acid; Male; Methylene Blue; Middle Aged; Prospective Studies; Pulmonary Circulation; Shock, Septic; Thermodilution; Vasoconstrictor Agents | 2002 |
Methylene blue administration in septic shock: a clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Oxidoreductases; Blood Pressure; Cardiac Output; Female; Guanylate Cyclase; Humans; Lactates; Lactic Acid; Male; Methylene Blue; Middle Aged; Nitric Oxide Synthase; Oxygen; Prospective Studies; Shock, Septic | 1995 |
Methylene blue increases myocardial function in septic shock.
Topics: Aged; Blood Gas Analysis; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Methylene Blue; Middle Aged; Myocardial Contraction; Nitric Oxide; Oxygen Consumption; Resuscitation; Shock, Septic | 1995 |
Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.
Topics: Adult; Arginine; Endothelium, Vascular; Female; Hemodynamics; Humans; Male; Matched-Pair Analysis; Methylene Blue; Nitric Oxide; Prospective Studies; Pulmonary Gas Exchange; Shock, Septic; Single-Blind Method; Time Factors; Vasodilation | 1995 |
Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Methylene Blue; Middle Aged; Nitric Oxide; Prospective Studies; Pulmonary Gas Exchange; Respiratory Distress Syndrome; Shock, Septic; Time Factors | 1998 |
Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue.
Topics: Adult; Analysis of Variance; Blood Pressure; Enzyme Inhibitors; Female; Humans; Lung; Male; Methylene Blue; Middle Aged; Nitric Oxide; Pilot Projects; Pregnancy; Prospective Studies; Respiratory Insufficiency; Shock, Septic; Vascular Resistance | 1999 |
Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study.
Topics: Adult; Aged; Blood Chemical Analysis; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hemodynamics; Hospitals, University; Humans; Infusions, Intravenous; Intensive Care Units; Male; Methylene Blue; Middle Aged; Pilot Projects; Probability; Prospective Studies; Reference Values; Respiratory Function Tests; Severity of Illness Index; Shock, Septic; Survival Rate; Treatment Outcome | 2001 |
42 other study(ies) available for methylene blue and Shock, Septic
Article | Year |
---|---|
Methylene blue for the treatment of refractory septic shock secondary to listeriosis in a paediatric patient.
Topics: Child; Child, Preschool; Extracorporeal Membrane Oxygenation; Female; Humans; Listeriosis; Methylene Blue; Shock, Septic; Vasoconstrictor Agents | 2022 |
Methylene Blue to Neonatal Septic Shock treatment in neonate pigs
Topics: Animals; Disease Models, Animal; Lactic Acid; Male; Methylene Blue; Neonatal Sepsis; Sepsis; Shock, Septic; Swine | 2022 |
Effect of methylene blue on hemodynamic response in the early phase of septic shock: A case series.
Topics: Blood Pressure; Hemodynamics; Humans; Lactates; Methylene Blue; Norepinephrine; Shock, Septic; Vasoconstrictor Agents | 2023 |
Methylene blue as adjunctive therapy in septic shock: correct drug diluent derives optimal efficacy.
Topics: Dental Care; Humans; Methylene Blue; Patients; Shock, Septic | 2023 |
Drug diluent and efficacy of methylene blue in septic shock: authors' reply.
Topics: Humans; Methylene Blue; Patients; Shock, Septic | 2023 |
Acute respiratory distress syndrome from Covid-19: A perfect storm from free radicals? Proposal for a new treatment.
Topics: Animals; COVID-19; Diagnosis, Differential; Free Radicals; Humans; Inflammation; Methylene Blue; Models, Theoretical; Reactive Nitrogen Species; Reactive Oxygen Species; Respiratory Distress Syndrome; Shock, Septic; Vascular Resistance | 2020 |
Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.
Topics: Acute Kidney Injury; Aged; Antibodies, Monoclonal, Humanized; Antioxidants; Ascorbic Acid; Betacoronavirus; Coronavirus Infections; Corynebacterium; Corynebacterium Infections; COVID-19; Cytokine Release Syndrome; Enzyme Inhibitors; Erythrocyte Transfusion; Hematinics; Humans; Hydroxocobalamin; Hydroxychloroquine; Hypoxia; Male; Methemoglobinemia; Methylene Blue; Pandemics; Pneumonia, Bacterial; Pneumonia, Viral; Renal Replacement Therapy; Respiratory Insufficiency; SARS-CoV-2; Shock, Septic | 2020 |
Greenish-blue discoloration of the brain and heart after treatment with methylene blue.
Topics: Accidents, Traffic; Brain; Enzyme Inhibitors; Female; Heart; Humans; Methylene Blue; Middle Aged; Myocardium; Shock, Septic | 2021 |
Methylene Blue Administration for Distributive Shock States in Critically Ill Children.
Topics: Blood Pressure; Child; Child, Preschool; Critical Illness; Fatal Outcome; Female; Humans; Infant; Infant, Newborn; Israel; Male; Methylene Blue; Retrospective Studies; Shock; Shock, Septic; Vasoplegia | 2020 |
Index of suspicion.
Topics: Anemia, Iron-Deficiency; Diagnosis, Differential; Diarrhea; Female; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Lymphohistiocytosis, Hemophagocytic; Male; Methemoglobinemia; Methylene Blue; Risk Assessment; Severity of Illness Index; Shock, Septic | 2014 |
Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shock.
Topics: Animals; Cell Adhesion; Disease Models, Animal; Endothelium, Vascular; Endotoxins; Hemodynamics; Intestines; Leukocytes; Lipopolysaccharides; Methylene Blue; Microcirculation; Norepinephrine; Pressure; Rats; Rats, Inbred Lew; Shock, Septic | 2014 |
A Novel Use of Methylene Blue in the Pediatric ICU.
Topics: Combined Modality Therapy; Enzyme Inhibitors; Female; Humans; Hypotension; Infant; Methylene Blue; Shock, Septic; Vasoplegia | 2015 |
In response to: "A systematic analysis of methylene blue for drug-induced shock".
Topics: Humans; Methylene Blue; Shock; Shock, Septic | 2017 |
A systematic analysis of methylene blue for drug-induced shock in humans.
Topics: Humans; Methylene Blue; Shock; Shock, Septic | 2017 |
Turquoise to dark green organs at autopsy.
Topics: Aged; Autopsy; Chromatography, High Pressure Liquid; Coronary Disease; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Hypertension; Male; Methylene Blue; Pancreatectomy; Pancreatic Neoplasms; Postoperative Complications; Shock, Septic; Sleep Apnea, Obstructive; Tissue Distribution | 2009 |
Use of methylene blue for refractory septic shock during continuous venovenous hemodiafiltration.
Topics: Accidents, Traffic; Acute Kidney Injury; Blood Pressure; Catecholamines; Contraindications; Drug Resistance; Fatal Outcome; Hemodiafiltration; Humans; Male; Methylene Blue; Middle Aged; Nitric Oxide; Renal Replacement Therapy; Sepsis; Shock, Septic; Vasoconstrictor Agents | 2010 |
The effects of methylene blue infusion on gastric tonometry and intestinal fatty acid binding protein levels in septic shock patients.
Topics: Aged; Aged, 80 and over; Enzyme Inhibitors; Fatty Acid-Binding Proteins; Female; Gastric Mucosa; Humans; Male; Manometry; Methylene Blue; Middle Aged; Prospective Studies; Shock, Septic; Treatment Outcome | 2010 |
A fictive unit for the cardiac work for at least 83 years.
Topics: Hemodynamics; History, 20th Century; History, 21st Century; Humans; Methylene Blue; Nitric Oxide; Shock, Septic; Stroke Volume; Terminology as Topic; Ventricular Function | 2010 |
Methylene blue as the future protecting agent for ischemic brain injury?
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Heart Arrest; Humans; Methylene Blue; Neuroprotective Agents; Reperfusion Injury; Shock, Septic | 2010 |
Prolonged methylene blue infusion in refractory septic shock: a case report.
Topics: Aged; Hemodynamics; Humans; Infusions, Intravenous; Male; Methylene Blue; Shock, Septic | 2011 |
Local cutaneous necrosis secondary to a prolonged peripheral infusion of methylene blue in vasodilatory shock.
Topics: Female; Humans; Infusions, Intravenous; Ischemia; Methylene Blue; Middle Aged; Necrosis; Shock, Septic; Skin; Vasoconstriction | 2012 |
Administration of methylene blue in human septic shock: renaissance of an old drug?
Topics: Blood Volume; Capillary Permeability; Guanylate Cyclase; Humans; Methylene Blue; Research Design; Risk Factors; Shock, Septic; Vasoconstrictor Agents | 2003 |
Congenital methemoglobinemia: a rare cause of cyanosis in the newborn--a case report.
Topics: Cyanosis; Cytochrome Reductases; Cytochrome-B(5) Reductase; Diagnosis, Differential; Female; Humans; Infant, Newborn; Male; Metabolism, Inborn Errors; Methemoglobin; Methemoglobinemia; Methylene Blue; Shock, Septic | 2003 |
Methylene blue revisited: management of hypotension in a pediatric patient with bacterial endocarditis.
Topics: Cardiopulmonary Bypass; Cerebrovascular Disorders; Child; Endocarditis, Bacterial; Enzyme Inhibitors; Female; Heart Valve Prosthesis Implantation; Humans; Hypotension; Methylene Blue; Mitral Valve; Shock, Septic; Staphylococcal Infections; Vasoconstrictor Agents | 2005 |
The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock.
Topics: Anti-Infective Agents, Urinary; Blood Pressure; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infusions, Intravenous; Male; Methylene Blue; Middle Aged; Pulmonary Circulation; Retrospective Studies; Shock, Septic; Treatment Outcome; Vascular Resistance | 2005 |
Methylene blue: an old-timer or a compound ready for revival?
Topics: Animals; Enzyme Inhibitors; Fluid Therapy; Heart Arrest; Humans; Inflammation; Methylene Blue; Reperfusion Injury; Shock, Septic | 2006 |
Short-term beneficial effects of methylene blue on kidney damage in septic shock patients.
Topics: Acute Kidney Injury; Aged; Analysis of Variance; Enzyme Inhibitors; Female; Glutathione Transferase; Humans; Male; Methylene Blue; Nitric Oxide Synthase; Prospective Studies; Shock, Septic; Treatment Outcome | 2008 |
Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock.
Topics: Animals; Dogs; Escherichia coli Infections; Female; Guanylate Cyclase; Hemodynamics; Male; Methylene Blue; Oxygen Consumption; Random Allocation; Regional Blood Flow; Shock, Septic | 1995 |
Methylene blue infusion in septic shock.
Topics: Coloring Agents; Humans; Methylene Blue; Nitric Oxide Synthase; Shock, Septic | 1995 |
Methylene blue infusion in septic shock.
Topics: Animals; Coloring Agents; Guanylate Cyclase; Hemodynamics; Humans; Infusions, Intravenous; Methylene Blue; Shock, Septic | 1995 |
Methylene blue reverses endotoxin-induced hypotension.
Topics: Animals; Blood Pressure; Cyclic GMP; Hypotension; Lipopolysaccharides; Methylene Blue; Nitric Oxide; Rabbits; Shock, Septic; Sulfhydryl Compounds | 1994 |
Arteriolar endothelium-dependent vasodilation occurs during endotoxin shock.
Topics: Acetylcholine; Animals; Arterioles; Endothelium, Vascular; Hemodynamics; Hydroquinones; Injections, Intra-Arterial; Injections, Intravenous; Male; Methylene Blue; Microcirculation; Nitric Oxide; Rats; Rats, Sprague-Dawley; Shock, Septic; Vasodilation | 1993 |
Effects of methylene blue in septic shock.
Topics: Animals; Humans; Methylene Blue; Oxidation-Reduction; Rats; Shock, Septic | 1996 |
Effect of methylene blue on refractory neonatal hypotension.
Topics: Blood Pressure; Diseases in Twins; Drug Evaluation; Female; Heart Rate; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Male; Methylene Blue; Nitric Oxide; Shock, Septic | 1996 |
Continuous infusion of methylene blue for septic shock.
Topics: Antidotes; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Methylene Blue; Middle Aged; Shock, Septic | 1996 |
[Inhibition of the nitric oxide pathway in refractory septic shock].
Topics: Adult; Aged; Aged, 80 and over; Dopamine; Female; Hemodynamics; Humans; Male; Methylene Blue; Middle Aged; Nitric Oxide; Norepinephrine; Prospective Studies; Shock, Septic | 1996 |
Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats.
Topics: Animals; Aorta; Blood Pressure; Charybdotoxin; Dexamethasone; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Escherichia coli; Guanidines; Guanylate Cyclase; Heart Rate; In Vitro Techniques; Lipopolysaccharides; Male; Methylene Blue; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Oxadiazoles; Quinoxalines; Rats; Rats, Inbred WKY; Shock, Septic; Tetraethylammonium | 1998 |
Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility.
Topics: Animals; Arginine; Blood Physiological Phenomena; Cyclic GMP; Drug Combinations; Enzyme Inhibitors; Humans; Interleukin-1; Methylene Blue; Myocardial Contraction; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nucleotides, Cyclic; omega-N-Methylarginine; Rats; Shock, Septic; Tumor Necrosis Factor-alpha | 1999 |
Shortening of cardiac action potentials in endotoxic shock in guinea pigs is caused by an increase in nitric oxide activity and activation of the adenosine triphosphate-sensitive potassium channel.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Cyclic GMP; Enzyme Inhibitors; Glyburide; Guanidines; Guinea Pigs; Lipopolysaccharides; Methylene Blue; NG-Nitroarginine Methyl Ester; Nitric Oxide; Papillary Muscles; Potassium Channels; Shock, Septic; Time Factors | 2000 |
Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep.
Topics: Animals; Consciousness; Endotoxemia; Endotoxins; Enzyme Inhibitors; Hemodynamics; Infusions, Intravenous; Injections, Intravenous; Methylene Blue; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pulmonary Gas Exchange; Respiratory Distress Syndrome; Sheep; Shock, Septic | 2001 |
Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations.
Topics: Adult; Aged; Combined Modality Therapy; Female; Hemodynamics; Humans; Methylene Blue; Norepinephrine; Respiration, Artificial; Shock, Septic; Vascular Resistance | 1992 |
Anti-tumoral and anti-inflammatory effects of biological stains.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Azure Stains; BCG Vaccine; Carrageenan; Female; Fibrosarcoma; Granuloma; Lipopolysaccharides; Male; Methylcholanthrene; Methylene Blue; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Shock, Septic; Tumor Necrosis Factor-alpha | 1991 |